Skip to main content
Jane Reusch, MD, Endocrinology, Aurora, CO

JaneReuschMD

Endocrinology Aurora, CO

Diabetes, Lipid Metabolism

Professor, Medicine, University of Colorado School of Medicine

Dr. Reusch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Reusch's full profile

Already have an account?

  • Office

    1700 Wheeling St
    Aurora, CO 80045
    Phone+1 913-578-4409

Summary

  • Jane EB Reusch, MD is a Professor of Medicine, Bioengineering and Integrative Physiology, and Associate Director of the Center for Women’s Health Research, Anschutz Medical Campus and staff physician and merit investigator at the Rocky Mountain Regional VAMC. She is an elected member of American Society for Clinical Investigation, American Association of Physicians and the American Diabetes Association 2018 President for Medicine and Science. She is currently working with the ADA, AHA and ACC on global strategies to decrease the cardiovascular burden of diabetes. She is dedicated to recruiting and mentoring the translational research workforce, especially in women’s health and diabetes.

    A physician-scientist, Dr. Reusch has made fundamental contributions to our understanding of cellular metabolism of diabetes and its complications. The focus of her basic science program is to identify the cellular and molecular mechanisms (i.e. mitochondrial dysfunction) that contribute to cardiac, vascular and skeletal muscle dysfunction in diabetes. Her shared clinical translational research program with Dr Judy Regensteiner examines and targets the biological variables in people with diabetes, particularly women, that lead to decreased functional exercise capacity and shortened lifespan.

Education & Training

  • University of Colorado
    University of ColoradoFellowship, Endocrinology, Diabetes, and Metabolism, 1989 - 1992
  • University of Colorado
    University of ColoradoResidency, Internal Medicine, 1986 - 1989
  • University of Minnesota Medical School
    University of Minnesota Medical SchoolClass of 1986
  • University of Notre Dame
    University of Notre DameBS, Biology and Theology, Cum Laude, 1977 - 1981
  • University of Notre Dame
    University of Notre DameB.S., Cum Laude, 1977 - 1981

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 1990 - 2025
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Elected Member American Association of Physicians AAP, 2005
  • Fellow Executive Leadership in Academic Medicine (ELAM), 2011
  • Clinical Merit Review Award VA, 2007
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • PhD Exenatide improves diastolic cardiac and endothelial function but not exercise capacity in individuals with type 2 diabetes  
    Scalzo RL, Herlache L, McMillin S, Gilligan S, Huebschmann AG, Bauer TA, Dorosz J, Reusch JEB* and Regensteiner JG, J Diabetes Complications, 1/7/2016
  • The Endothelial Glycocalyx Promotes Homogeneous Blood Flow Distribution within the Microvasculature  
    McClatchey PM, Schafer M, Hunter KS, Reusch JEB, Am J Physiol Heart Circ Physiol, 1/1/2016
  • Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes  
    Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, B..., Diabetes N Engl J Med, 1/1/2016
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Oxygen-carrying capacity is impaired by lipid/heparin infusion in young healthy adults
    McClatchey PM, Reusch JEB, Regensteiner JG, Schauer IE, 1/1/2016
  • The Endothelial Glycocalyx Promotes Homogenous Blood Flow Distribution Within the Microvasculature
    McClatchey PM, Schafer M, Hunter KS, Reusch JEB, AHA-ATVB meeting, Nashville, TN, 1/1/2016
  • Novel insights into mitochondrial dysfunction in diabetes: muscle oxidative function and O2 delivery limitations
    Cree-Green M, McClatchey PM, Bauer T, Knaub L, McMillin S, Leavitt I, Schauer IE, Regensteiner JG, Reusch JEB, NIH Mitochondrial Symposium, Bethesda, MD, 1/1/2016
  • Join now to see all

Lectures

  • Women’s Networking, Exercise, and Debates: My Experience at ADA 2020 
    Aurora, CO - 6/15/2014
  • Emerging Aspects of Adaptations to Exercise 
    ENDO 2019 - New Orleans, LA - 3/24/2019
  • Master Clinician: Management of Diabetes: Selecting Therapy Based on CVD Outcomes and Beyond 
    ENDO 2019 - New Orleans, LA - 3/24/2019
  • Join now to see all

Other

  • Evaluating the Cardiovascular Effects of TZDs and their Place in the Management of T2D in Relation to the Metabolic Syndrome, Metabolic Syndrome and Related Disorders 
    Nesto et al discussion group
    1/1/2005

Authored Content

  • ADA 2022: A Personal ReflectionJune 2022
  • Reflections on a Virtual ENDO 2021 MeetingMarch 2021
  • Women’s Networking, Exercise, and Debates: My Experience at ADA 2020June 2020

Press Mentions

  • Sex-Specific Guidelines Needed for Treating Obesity, Hypertension and Diabetes in Women
    Sex-Specific Guidelines Needed for Treating Obesity, Hypertension and Diabetes in WomenApril 11th, 2022
  • University of Colorado Tops $1 Billion in Sponsored Research Funding for Fourth Consecutive Year
    University of Colorado Tops $1 Billion in Sponsored Research Funding for Fourth Consecutive YearOctober 8th, 2020
  • Top Designation for CU Anschutz Medical Campus Expands Research Reach
    Top Designation for CU Anschutz Medical Campus Expands Research ReachSeptember 28th, 2020
  • Join now to see all

Professional Memberships